Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure.
Ontology highlight
ABSTRACT: Selective serotonin reuptake inhibitors (SSRIs) are frequently prescribed to pregnant women. Therefore, research on in utero exposure to SSRIs can be helpful in informing patients and clinicians. The aim of this retrospective two-cohort study was to determine whether there is a statistically significant increase in Chiari I malformations (CIM) in children exposed to SSRIs during pregnancy. A total of 33 children whose mothers received a diagnosis of depression and took SSRIs during pregnancy (SSRI-exposed cohort) were matched to 66 children with no history of maternal depression and no SSRI exposure. In addition, 30 children whose mothers received a diagnosis of depression, but did not receive antidepressants during pregnancy (history of maternal depression cohort), were matched to 60 chil
SUBMITTER: Knickmeyer RC
PROVIDER: S-EPMC4207341 | biostudies-literature | 2014 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA